Drugs News and Research

RSS

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

28 Jan 2010

Zelos Therapeutics commences dosing in clinical study of ZT-034 nasal spray for osteoporosis

Zelos Therapeutics, Inc. has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034 (teriparatide) that is being developed in collaboration with development partner Aegis Therapeutics, LLC. Nasal spray ZT-034 is being developed as an alternative to Eli Lilly and Company’s Forteo (teriparatide [rDNA origin]) which generated approximately $800M in annual sales in 2009 for the treatment of osteoporosis and is administered by daily injection.

28 Jan 2010

Ligand Pharmaceuticals acquires Metabasis Therapeutics

Ligand Pharmaceuticals Incorporated announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX), following approval of the transaction by Metabasis stockholders yesterday. As a result, Ligand gains a fully funded partnership with Roche, additional pipeline assets and drug discovery technologies and resources. The transaction was first announced on October 27, 2009.

28 Jan 2010

Celgene reports total revenue of $758M for fourth-quarter of 2009

Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $290.3 million, or non-GAAP diluted earnings per share of $0.62 for the quarter ended December 31, 2009. Non-GAAP net income for the fourth quarter of 2008 was $200.9 million or non-GAAP diluted earnings per share of $0.43. Based on U.S. GAAP, Celgene reported net income of $254.2 million, or diluted earnings per share of $0.54 for the quarter ended December 31, 2009. GAAP net loss for the fourth quarter of 2008 was $149.3 million, or diluted loss per share of $0.33.

28 Jan 2010

Baxter International reports net income of $572M for the fourth-quarter of 2009

Baxter International Inc. today reported strong performance for the fourth quarter of 2009, and provided its financial outlook for the first quarter and full-year 2010.

From Baxter International Inc. 28 Jan 2010

Scientists discover mechanism that regulates prolactin hormone

A mechanism for regulating the hormone prolactin has newly been revealed by scientists at Karolinska Institutet. The results are to be published in the scientific journal Neuron, and may be significant for conditions and functions such as breast-feeding, sexual libido, and metabolism.

28 Jan 2010

Interdisciplinary team evaluates the economic impact of mental illness in Spain

An interdisciplinary team coordinated by researchers from the University of Castilla La Mancha (UCLM) and the Canary Islands Health Service has evaluated the economic impact of mental illness in Spain, and estimated their social cost. According to the study, despite health resources being invested to alleviate the effects of such illnesses, informal care and lost work time places a heavy burden on society.

28 Jan 2010

Humans' evolutionary advantage also makes them susceptible to cancer, dementia and heart disease

The same evolutionary genetic advantages that have helped increase human lifespans also make us uniquely susceptible to diseases of aging such as cancer, heart disease and dementia, reveals a study to be published in a special PNAS collection on "Evolution in Health and Medicine" on Tuesday, Jan. 26.

28 Jan 2010

Scientific and regulatory experts to discuss global and domestic public health issues

The United States Pharmacopeial Convention (USP) will convene a meeting of its member organizations on April 21󈞄 in Washington, D.C. Member delegates and experts from around the world will gather to discuss pressing global and domestic public health issues.

28 Jan 2010

Workers' compensation status may affect treatment outcomes for herniated disks

Surgery provides better results than nonsurgical treatment for most patients with back pain related to a herniated disk—but not for those receiving workers' compensation for work-related injuries, reports a study in the January 1 issue of Spine.

28 Jan 2010

Study shows ActiveHealth's VBID programs increase adherence to medications

ActiveHealth Management (ActiveHealth®), a subsidiary of Aetna, today announced the publication of a paper in the February issue of Health Affairs. The paper demonstrates that properly structured value-based insurance design (VBID) programs can be effective at increasing adherence to drug regimens for specific chronic medical conditions without increasing overall costs.

28 Jan 2010

Posible new method to assess loss of consciousness

The brains of people under anesthesia respond to stimuli as they do in the deepest part of sleep - lending credence to a developing theory of consciousness and suggesting a new method to assess loss of consciousness in conditions such as coma.

28 Jan 2010

MedPage Today publishes most read medical stories

Which medical news stories are physicians reading to stay informed about key developments? MedPage Today publishes the Most Read Stories for the Past Week.

28 Jan 2010

New research findings may lead to new treatment options for abdominal aortic aneurysms

New research findings from a team at the Providence Heart + Lung Institute at St. Paul's Hospital and the University of British Columbia (UBC) may lead to new treatment options for abdominal aortic aneurysms (AAA) - a potentially fatal disease that currently has no pharmacological treatments.

28 Jan 2010

Special issue explores how evolution can help doctors understand and treat diseases

What does evolution - a field that often deals with changes over many generations - have to do with preventing and treating disease in our lifetime?

28 Jan 2010

Scientists discover new technique to investigate cancer stem cells

Scientists at Oxford University, funded by Cancer Research UK, have discovered a way to investigate cancer stem cells more efficiently in the laboratory.

28 Jan 2010

Leukemia cells rely on fatty acid metabolism to grow and evade cell death

Leukemia cells, like most cancers, are addicted to glucose to generate their energy, but new research shows for the first time that these cells also rely on fatty acid metabolism to grow and to evade cell death.

28 Jan 2010

Software tool helps medical service providers respond to serious incidents and disasters affecting children

A statistical study by a specialist group at Childrens Hospital Los Angeles and the University of Southern California indicates that the victims of the January 12 quake include an extraordinarily high number of children- more than 110,000, nearly half of the estimated total.

28 Jan 2010

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.

28 Jan 2010

Brighton Hospital signs letter of intent to build an addiction treatment facility in Riyadh

Brighton Hospital, the second-oldest alcohol and drug treatment provider in North America, has signed a letter of intent to begin a long-term management contract with a Saudi Arabian company to build a 291,000 square-foot, 250 bed addiction treatment facility in Riyadh, to serve the entire Islamic Mideast.

28 Jan 2010